If this is your first visit, be sure to
check out the FAQ by clicking the
link above. You may have to register
before you can post: click the register link above to proceed. To start viewing messages,
select the forum that you want to visit from the selection below.
Biopharm that experienced a failed Phase 2 test last week. Institutional buyers immediately jumped in, however, the next day. IIRC, they have 80+ more drugs under development and a few joint venture agreements in hand.
A biopharm tiddler that retraced 38.2% of its move from the November low (the last time it touched the 200DMA) to the Feb. high. Moving higher after breaking out through the descending resistance line.
Looks like a breakout day.....been basing since early December....also, I suppose that could be a cup and handle. Got a short term 3 day target of 47 on this one.
TRID - small symmetrical triangle with a bearish divergence between price and stochstics/RSI. Not much room to drop before hitting strong support, however (the 20-day EMA).
TRID - small symmetrical triangle with a bearish divergence between price and stochstics/RSI. Not much room to drop before hitting strong support, however (the 20-day EMA).
The SPY's ADX is 14.62, indicating a flat market. Daily stochastics are overbought and today's bar closed near the bottom of its range. There's a setup here for a stochastic pop but if volume continues very weak, we could see a sharp move lower.
Comment